优化1-Methyl-3-(pyridin-3-yl)-1H-indol衍生物作为ROR1抑制剂,提高活性和选择性
Qingquan Zheng1, Xingyang Qiu1, Dongdong Luo1
1Center for Molecular Oncology, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu 610041, China.
研究人员优化了LDR102,一种以醇为基础的化合物,以创建一个高度选择性的小分子抑制剂,向ROR1 (受体氨酸激酶类孤儿受体1). 这种新化合物,24d,显示出强大的抗瘤活性和改善了癌症治疗的药理动力学特征.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 受体氨酸激酶类孤儿受体1 (ROR1) 是瘤学中的一个关键目标,因为它在癌症恶性瘤中的作用.
- 现有的针对ROR1的生物药物正在临床试验中,但选择性小分子抑制剂很少.
- 之前的工作确定了LDR102作为一种新型ROR1抑制剂,但指出了非目标激酶活性和亚最佳药理动力学 (PK).
研究的目的:
- 解决LDR102的局限性,特别是其非目标效应和PK概况.
- 开发一种具有增强治疗潜力的ROR1新型选择性小分子抑制剂.
主要方法:
- 对LDR102脚手架的系统优化.
- 合成和评估一系列的1-甲基-3-(pyridin-3-yl) -1-H-醇衍生物.
- 评估ROR1抑制功效,选择性,体外/体内抗瘤活性和PK概况.
主要成果:
- 发现化合物24d,一种强效和选择性的ROR1抑制剂.
- 化合物24d在体外和体内表现出强大的抗瘤疗效.
- 为24d实现了优化的PK配置,克服了母化合物的局限性.
结论:
- 化合物24d在选择性ROR1小分子抑制剂的开发中取得了重大进展.
- 优化的衍生品表现出在瘤学中进一步临床前和临床开发的有前途特征.
- 这项研究突出了成功的脚手架优化策略,用于开发向癌症治疗方法.
更多相关视频
06:18Syntheses, Crystallization, and Spectroscopic Characterization of 3,5-Lutidine N-Oxide Dehydrate
Published on: April 24, 2018
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Regioselectivity and Stereochemistry of Hydroboration
Hydroboration proceeds in a concerted fashion with the attack of borane on the π bond, giving a cyclic four-centered transition state. The –BH2 group is bonded to the less substituted carbon and –H to the more substituted carbon. The concerted nature requires the simultaneous addition of –H and –BH2 across the same face of the alkene giving syn...
